Literature DB >> 17052957

Polymorphisms of TGF-beta1 in cystic fibrosis patients.

Jitka Brazova1, Kristyna Sismova, Vera Vavrova, Jana Bartosova, Milan Macek, Hynek Lauschman, Anna Sediva.   

Abstract

There is a significant phenotypic variance among cystic fibrosis (CF) patients. Due to the role of TGF-beta1 in fibrotic processes we investigated its role in CF pathogenesis. TGF-beta 1 codons 10 and 25 were genotyped in 118 Czech CF patients and 268 controls by PCR-ARMS. Difference between CF and controls was found at codon 10, lower frequency of T/T homozygotes, and codon 25, higher frequency of G/C heterozygotes. We did not prove the association of TGF-beta1 polymorphisms and lung function in CF, however, the TT (codon 10)/GG (codon 25) genotype was preferentially associated with CF-related liver disease and diabetes. Independent of the TGF-beta1 genotype, production of cytokine was higher in patients than in controls with the notable exception of very low levels in Burkholderia cepacia complex colonized patients. In CF, both extremes, highest or lowest TGF-beta 1 production, were associated with impaired lung function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052957     DOI: 10.1016/j.clim.2006.08.015

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  17 in total

1.  The influence of genetics on cystic fibrosis phenotypes.

Authors:  Michael R Knowles; Mitchell Drumm
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 2.  Modifier genes in Mendelian disorders: the example of cystic fibrosis.

Authors:  Garry R Cutting
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

3.  Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.

Authors:  William T Harris; Marianne S Muhlebach; Robert A Oster; Michael R Knowles; J P Clancy; Terry L Noah
Journal:  Pediatr Pulmonol       Date:  2011-02-18

4.  CFTR dysfunction predisposes to fibrotic liver disease in a murine model.

Authors:  Camilia R Martin; Munir M Zaman; Gyanprakash A Ketwaroo; Abdul Q Bhutta; Emmanuel Coronel; Yury Popov; Detlef Schuppan; Steven D Freedman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-07       Impact factor: 4.052

Review 5.  Update on gene modifiers in cystic fibrosis.

Authors:  Joseph M Collaco; Garry R Cutting
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

6.  Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.

Authors:  Theodore J Cory; Susan E Birket; Brian S Murphy; Cynthia Mattingly; Jessica M Breslow-Deckman; David J Feola
Journal:  J Antimicrob Chemother       Date:  2012-12-17       Impact factor: 5.790

7.  Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus.

Authors:  T L Rivera; P M Izmirly; B K Birnbaum; P Byrne; J B Brauth; M Katholi; M Y Kim; J Fischer; R M Clancy; J P Buyon
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

8.  Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.

Authors:  J Michael Collaco; Lori Vanscoy; Lindsay Bremer; Kathryn McDougal; Scott M Blackman; Amanda Bowers; Kathleen Naughton; Jacky Jennings; Jonathan Ellen; Garry R Cutting
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

9.  Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.

Authors:  Lindsay A Bremer; Scott M Blackman; Lori L Vanscoy; Kathryn E McDougal; Amanda Bowers; Kathleen M Naughton; David J Cutler; Garry R Cutting
Journal:  Hum Mol Genet       Date:  2008-04-17       Impact factor: 6.150

10.  Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases.

Authors:  Sophie Collardeau-Frachon; Raymonde Bouvier; Catherine Le Gall; Christine Rivet; Faiza Cabet; Gabriel Bellon; Alain Lachaux; Jean-Yves Scoazec
Journal:  Virchows Arch       Date:  2007-06-07       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.